Synlogic, Inc. (SYBX)

$1.50 -0.66% $-0.01 Healthcare

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd; Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.

$17.54M

Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc

84.00

Cambridge, MA

Sep 30, 2015

-0.32

$-4.63

4.80

5.15

-6,383.28%

-2.33

0.02

2.70

18.01

4.80

-79.95%

-82.72%

Similar stocks (21)

Edgewise Therapeutics, Inc.

EWTX

$19.07 5.50%
Uptrend

4D Molecular Therapeutics, Inc.

FDMT

$16.82 4.08%
Downtrend

Erasca, Inc.

ERAS

$2.89 0.00%
Uptrend

Stoke Therapeutics, Inc.

STOK

$15.22 0.66%
Uptrend

Third Harmonic Bio, Inc.

THRD

$13.50 5.88%
Uptrend

C4 Therapeutics, Inc.

CCCC

$6.38 -1.24%
Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$5.95 0.51%
Neutral

Generation Bio Co.

GBIO

$2.59 -1.89%
Downtrend

Kronos Bio, Inc.

KRON

$0.92 -2.42%
Downtrend

Passage Bio, Inc.

PASG

$0.70 -3.60%
Downtrend

Protara Therapeutics, Inc.

TARA

$1.92 5.49%
Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.06 0.00%
Downtrend

Surrozen, Inc.

SRZN

$8.01 -2.44%
Downtrend

SAB Biotherapeutics, Inc.

SABS

$2.56 -7.58%
Downtrend

Monopar Therapeutics Inc.

MNPR

$3.94 -5.29%
Neutral

Vaccinex, Inc.

VCNX

$5.16 -11.34%
Downtrend

Processa Pharmaceuticals, Inc.

PCSA

$1.42 -1.39%
Downtrend

Fresh Tracks Therapeutics, Inc.

FRTX

$0.74 0.00%
Downtrend

Galera Therapeutics, Inc.

GRTX

$0.08 13.57%
Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00%
Downtrend

eFFECTOR Therapeutics, Inc.

EFTR

$0.04 -11.11%
Downtrend

ETF Exposure (5)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$136.02 0.03%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.99 -0.24%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$277.35 -0.25%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.97 -0.24%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$179.34 0.03%
Uptrend